<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3802</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2021.SP216</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Association of CRP Levels as an Inflammatory Marker in Prognosis of COVID-19 Cases&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>K</surname><given-names>Sharanya</given-names></name></contrib><contrib contrib-type="author"><name><surname>K</surname><given-names>Lakshmi</given-names></name></contrib><contrib contrib-type="author"><name><surname>K</surname><given-names>Vinod</given-names></name></contrib><contrib contrib-type="author"><name><surname>S</surname><given-names>Chitralekha</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>11</day><month>06</month><year>2021</year></pub-date><volume>Wa</volume><issue>OV</issue><fpage>98</fpage><lpage>100</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: The pandemic COVID-19 is an important global threat because of its high infectivity and case fatality rate in high-risk patients. The studies related to physiological mechanisms, pathogenesis, effective laboratory diagnostic methods are still in investigative stages. Several studies on COVID-19 report that inflammatory reactions play a vital role in disease progression. Objective: In this study, we evaluated the association between the C-Reactive Protein (CRP) and the severity of COVID-19 pneumonia. This study would help the clinicians to monitor the prognosis and severity of the disease. Methods: A Retrospective study conducted in the Department of Microbiology over 3 months with 336 laboratories confirmed Corona positive patients. Blood samples were collected from these patients and CRP was estimated by the Latex Agglutination test. Results: Of the 336 patients, 142 (42.2) showed positive results for CRP. Among CRP positive cases, 67 showed high CRP(__ampersandsigngt;24mg/L) and 75 showed low CRP(__ampersandsignle;24mg/L). High CRP was found to be associated with increased severity of the illness. Conclusion: CRP may be a marker of disease severity and may be a valuable indicator for determining the severity of patients with COVID-19. Continuous CRP monitoring may also predict the prognosis of cases. Further investigations are required to demonstrate the mechanisms by which increased CRP is seen in patients suffering from SARS- CoV-2.&#13;
</p></abstract><kwd-group><kwd>CRP</kwd><kwd> Covid-19</kwd><kwd> Inflammatory marker</kwd><kwd> Corona Virus</kwd><kwd> Pandemi</kwd></kwd-group></article-meta></front></article>
